Completed NA INTERVENTIONAL NCT00774904

Adiponectin and Insulin Resistance in Diabetic Nephropathy

Adiponectin is Positively Associated With Insulin Resistance in Subjects With Type 2 Diabetic Nephropathy and Effects by Angiotensin Type 1 Receptor Blocker Losartan

Sponsor: Shanghai Jiao Tong University School of Medicine

Conditions Diabetic Nephropathy

Interventions Losartan

Updated 2 times since 2024 Last updated: Oct 17, 2008 Started: Apr 30, 2007 Primary completion: Oct 31, 2007 Completion: Nov 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetic Nephropathy, this trial is completed. The trial is conducted by Shanghai Jiao Tong University School of Medicine and has accumulated 2 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

2 versions recorded

Feb 2025 — Present [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Jiao Tong University School of Medicine
Xi'an Jiaotong University

Data source: Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China